Dermatology · Freehold, NJ
NPI
1104024165
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
901 W Main St, Suite 201
Freehold, NJ, 07728
Phone (732) 637-9982
Groups this clinician bills Medicare through
Medicare paid, 2024
$309K
6,492 services
Medicare patients, 2024
721
Average age 74
Drug cost, 2024
$367K
927 prescriptions
Company payments, 2025
$36K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Swarna P Sivanesan was code 17003 (destruction skin lesion), 2,075 times for 261 patients. In total Swarna P Sivanesan billed 6,492 services in 46 codes, and Medicare paid $309K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,075 | 261 | $5.85 | $12K |
| 99213 Office E&M - Established | Office | 776 | 440 | $72.89 | $57K |
| 99214 Office E&M - Established | Office | 619 | 348 | $103.17 | $64K |
| 17000 Destruction Skin Lesion | Office | 519 | 305 | $40.20 | $21K |
| 17110 Destruction Skin Lesion | Office | 493 | 312 | $94.15 | $46K |
| 11102 Skin Biopsy | Office | 378 | 298 | $70.29 | $27K |
| 11103 Skin Biopsy | Office | 135 | 89 | $44.41 | $5,995 |
| 99204 Office E&M - New | Office | 87 | 87 | $125.21 | $11K |
| 99203 Office E&M - New | Office | 70 | 70 | $85.82 | $6,008 |
| 17004 Destruction Skin Lesion | Office | 59 | 41 | $145.88 | $8,607 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 33 | 14 | $0.77 | $25.53 |
| 11900 Skin | Office | 30 | 17 | $40.20 | $1,206 |
| 17262 Destruction Skin Lesion | Office | 27 | 21 | $143.88 | $3,885 |
| 12031 Wound Repair - All Levels | Office | 24 | 22 | $226.67 | $5,440 |
| 17111 Destruction Skin Lesion | Office | 23 | 15 | $108.20 | $2,489 |
By year: 2022 $205K for 5,318 services; 2023 $249K for 4,817 services; 2024 $309K for 6,492 services.
Medicare prescription drug claims, 2024
In 2024, the drug Swarna P Sivanesan prescribed most often to Medicare patients was Ketoconazole, with 146 prescriptions and refills. In total Swarna P Sivanesan wrote 927 Medicare prescriptions that cost $367K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 146 | 158 | 102 | $2,718 |
| Triamcinolone Acetonide Generic | 102 | 108 | 91 | $846 |
| Clobetasol Propionate Generic | 61 | 63 | 50 | $2,585 |
| Clindamycin Phosphate Generic | 60 | 66 | 54 | $1,953 |
| Metronidazole Generic | 57 | 58 | 36 | $1,729 |
| Mupirocin Generic | 54 | 54 | 45 | $442 |
| Doxycycline Hyclate Generic | 47 | 52 | 26 | $1,242 |
| Tacrolimus Generic | 37 | 47 | 27 | $2,895 |
| Desonide Generic | 28 | 28 | 27 | $1,240 |
| Betamethasone Dipropionate Generic | 28 | 28 | 24 | $853 |
| Spironolactone Generic | 27 | 61 | Under 11 | $268 |
| Fluorouracil Generic | 20 | 20 | 19 | $1,321 |
| Dupixent Pen Dupilumab | 18 | 18 | Under 11 | $67K |
| Otezla Apremilast | 16 | 16 | Under 11 | $77K |
| Pimecrolimus Generic | 15 | 15 | 15 | $4,017 |
Brand drugs: 143 claims; generic drugs: 784 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Swarna P Sivanesan $36K ($36K in general payments such as food, travel and fees) from 18 companies. The largest payer was Amgen Inc. with $34K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 47 | $34K |
| Incyte Corporation INCY | 36 | $479 |
| Abbvie Inc. ABBV | 28 | $468 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $350 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 17 | $349 |
| Mayne Pharma Commercial LLC | 23 | $337 |
| Lilly USA, LLC LLY | 11 | $195 |
| Genzyme Corporation SNY | 3 | $171 |
| Galderma Laboratories, L.P. GALD.SW | 25 | $162 |
| LEO Pharma Inc. | 5 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.